DK0570575T3 - Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf - Google Patents

Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf

Info

Publication number
DK0570575T3
DK0570575T3 DK93901000T DK93901000T DK0570575T3 DK 0570575 T3 DK0570575 T3 DK 0570575T3 DK 93901000 T DK93901000 T DK 93901000T DK 93901000 T DK93901000 T DK 93901000T DK 0570575 T3 DK0570575 T3 DK 0570575T3
Authority
DK
Denmark
Prior art keywords
complexes
conjugates
preparation
contrast agents
bicycloazamacrocyclophosphonic
Prior art date
Application number
DK93901000T
Other languages
Danish (da)
English (en)
Inventor
Jaime Simon
Garry E Kiefer
Joseph R Garlich
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Application granted granted Critical
Publication of DK0570575T3 publication Critical patent/DK0570575T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93901000T 1991-12-10 1992-12-10 Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf DK0570575T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80555191A 1991-12-10 1991-12-10
PCT/US1992/010668 WO1993011802A1 (fr) 1991-12-10 1992-12-10 Acides bicycloazamacrocyclophosphoniques, conjugues, agents de contraste et leur preparation

Publications (1)

Publication Number Publication Date
DK0570575T3 true DK0570575T3 (da) 1998-08-24

Family

ID=25191891

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93901000T DK0570575T3 (da) 1991-12-10 1992-12-10 Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf

Country Status (18)

Country Link
EP (2) EP0735040A3 (fr)
JP (1) JPH07502043A (fr)
CN (1) CN1038328C (fr)
AT (1) ATE160943T1 (fr)
AU (1) AU3246893A (fr)
CA (1) CA2103556C (fr)
DE (1) DE69223504T2 (fr)
DK (1) DK0570575T3 (fr)
ES (1) ES2110593T3 (fr)
GR (1) GR3026121T3 (fr)
HK (1) HK1006654A1 (fr)
HU (1) HUT66220A (fr)
IL (1) IL104060A (fr)
MX (1) MX9207166A (fr)
RU (1) RU2114115C1 (fr)
SG (1) SG46598A1 (fr)
WO (1) WO1993011802A1 (fr)
ZA (1) ZA929576B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385893A (en) * 1993-05-06 1995-01-31 The Dow Chemical Company Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
JPH08509976A (ja) * 1993-05-06 1996-10-22 ザ・ダウ・ケミカル・カンパニー コントラスト剤として使用するためのビシクロポリアザマクロシクロホスホン酸、それらの錯体および複合体ならびにそれらの製造方法
US6207826B1 (en) 1995-03-27 2001-03-27 Isis Pharmaceuticals, Inc. Macrocyclic compounds having nitrogen-containing linkages
US6107482A (en) * 1995-03-27 2000-08-22 Isis Pharmaceuticals, Inc. Nitrogenous macrocyclic compounds
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
EP0898574B1 (fr) * 1996-04-19 2003-11-12 Dow Global Technologies Inc. Chelates fluorescents utilises en tant qu'agents visuels destines a l'imagerie et specifiques de certains tissus
US5888476A (en) * 1996-11-13 1999-03-30 Mallinckrodt Medical, Inc. Magnetic resonance blood pool agents
US6440389B1 (en) 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
BRPI0922779A8 (pt) * 2008-12-05 2018-06-19 Molecular Insight Pharm Inc complexos de tecnécio e rênio-bis(heteroarila) e métodos de uso dos mesmos para inibir psma
NO331773B1 (no) * 2009-12-18 2012-03-26 Ge Healthcare As Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
RU2769699C2 (ru) * 2016-12-21 2022-04-05 ДжиИ Хелткер АС Хелатные соединения марганца на основе тетраазабицикло-макроцикла, подходящие в качестве визуализирующих агентов для MRI

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4001655A1 (de) * 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE3825040A1 (de) * 1988-07-20 1990-01-25 Schering Ag 5- oder 6-ring- enthaltende makrocyclische polyaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
FR2644785B1 (fr) * 1989-03-24 1991-07-05 Guerbet Sa Nouveaux ligands macrocycliques azotes, procede de preparation, complexes metalliques formes par ces ligands et composition de diagnostic les contenant
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
GB9001245D0 (en) * 1990-01-19 1990-03-21 Salutar Inc Compounds
WO1991010669A1 (fr) * 1990-01-19 1991-07-25 Cockbain, Julian, Roderick, Michaelson Composes de chelation

Also Published As

Publication number Publication date
CA2103556C (fr) 2002-04-16
ES2110593T3 (es) 1998-02-16
EP0570575A1 (fr) 1993-11-24
ZA929576B (en) 1994-06-10
EP0735040A3 (fr) 1997-02-26
IL104060A (en) 1998-12-06
DE69223504D1 (de) 1998-01-22
GR3026121T3 (en) 1998-05-29
ATE160943T1 (de) 1997-12-15
HU9302312D0 (en) 1993-12-28
CA2103556A1 (fr) 1993-06-11
HUT66220A (en) 1994-10-28
WO1993011802A1 (fr) 1993-06-24
HK1006654A1 (en) 1999-03-12
AU3246893A (en) 1993-07-19
JPH07502043A (ja) 1995-03-02
SG46598A1 (en) 1998-02-20
EP0735040A2 (fr) 1996-10-02
DE69223504T2 (de) 1998-04-02
RU2114115C1 (ru) 1998-06-27
CN1074447A (zh) 1993-07-21
CN1038328C (zh) 1998-05-13
IL104060A0 (en) 1993-05-13
MX9207166A (es) 1993-07-01
EP0570575B1 (fr) 1997-12-10

Similar Documents

Publication Publication Date Title
FI955319A0 (fi) 2-pyridyylimetyleenipolyatsamakrosyklofosfonihappoja, niiden komplekseja ja johdannaisia käytettäväksi vasta-aineina
FI955336A0 (fi) Varjoaineina käytettäviä trisyklopolyatsamakrosyklofosfonihappoja, niiden komplekseja ja johdannaisia
DK0570575T3 (da) Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf
EP0579802A4 (en) Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents
RU93053767A (ru) Бициклополиазамакроциклофосфоновые кислоты, их комплексы и конъюгаты для применения в качестве контрастных агентов и способы их получения
NO954442L (no) Bicyklopolyazamakrocyklofosfonsyrer, deres komplekser og konjugater, for anvendelse som kontrastmidler, og fremgangsmåter for deres fremstilling
MY141501A (en) Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents and processes for their preparation
RU93053897A (ru) Комплексы бициклополиазамакроциклокарбоновых кислот, их конъюгаты, фармацевтическая композиция, способ диагностики, набор и способ получения
MY109649A (en) Bicyclopol yazamacrocyclocarboxylic acid complexes, and conjugates, processes for their prepration, and use as contrast agents